New combo treatment targets Crow's feet and hollow eyes
NCT ID NCT07398755
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study observed 29 adults receiving a combination of botulinum toxin (Letybo), hyaluronic acid filler (Saypha Volume Plus), and polynucleotide injections (Philart Eye) around the eyes. The goal was to see how well this holistic approach reduces wrinkles and restores volume over 22 weeks. Researchers measured skin changes and patient satisfaction at several follow-up visits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- botulinum toxin A, hyaluronic acid filler, and polynucleotide
- What this could lead to
- If successful, this could confirm that a combination of these injectable treatments safely improves wrinkles and volume loss around the eyes for several months.
- What could go wrong
- This is a small, completed observational study with only 29 participants. Results may not apply to everyone, and the effects are temporary, requiring repeat treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLABELLAR LINES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
YUVELL
Vienna, State of Vienna, 1010, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a One-Two injection punch smooth frown lines better?
- New wrinkle treatment aims to rival botox in Head-to-Head trial
- New wrinkle treatment shows promise in asian trial
- New frown line combo treatment under study
- New Frown-Line treatment shows promise in large trial
- Botox study shows promise for smoothing upper face wrinkles